|Articles|November 30, 2015
Erick Gaussens
Author(s)Erick Gaussens
Advertisement
Erick Gaussens is Chief Scientific Officer at ProductLife Group
egaussens@productlife-group.com
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Boehringer Ingelheim Expands Immunology Pipeline With Preclinical Antibody Licensing Deal
2
Marty Makary Out as FDA Commissioner: Report
3
Eli Lilly’s Foundayo and Lower-Dose Zepbound Helped Maintain Weight Loss in Patients Switching from Injectables
4
Rigel Pharmaceuticals Enters $85 Million Agreement for Exclusive Global Rights to Veppanu
5